Celltrion Launches Higher-Strength Yuflyma Adalimumab In Canada

Public And Private Listings For Reimbursement Are In The Works

launch
Health Canada approval was received on Christmas Eve 2021 • Source: Alamy

More from Products

More from Generics Bulletin